Docteur en biologie et physiologie, chercheur en micronutrition clinique. Président de la SOFNNA et fondateur de l’Institut International des Sciences de la Nutrition et de la Micronutrition (IINMS).
Dr Amin Gasmi, PhD étudie les mécanismes métaboliques, la micronutrition cellulaire, la toxicologie des métaux lourds et le microbiote intestinal. Il coordonne des programmes de formation destinés aux professionnels de santé en France et dans l’espace francophone.
Travaux et publications scientifiques
Auteur et co-auteur de plus de 230 publications évaluées par les pairs (plus de 3 500 citations, h-index 32, classé dans le Top 2 % des scientifiques mondiaux Stanford / Elsevier), il publie dans des revues internationales telles que Critical Reviews in Food Science and Nutrition, Seminars in Cancer Biology, Nutrients, Current Neuropharmacology, Pharmacological Reports et Pharmaceuticals.
Profils académiques : Articles de recherche sur OrthoDiet · PubMed · ResearchGate · ORCID
Publications scientifiques récentes
Toutes les publications (146)AI-integrated Approaches in Alzheimer’s Disease: Linking Molecular Pathways, Biomarkers, and Emerging Therapies
Objective: Alzheimer's disease (AD) continues to be the leading cause of dementia worldwide, due to its complicated, multifactorial pathophysiology. To shift the AD paradigm from reactive to proactive, from a specific time to a precision…
A systematic review of Cinnamomum Bioactives in metabolic and inflammatory disorders: integrating species-specific differences, extraction technologies, and clinical translation
Publication scientifique évaluée par les pairs signée par Ankita Wal, K K Sharma, Subhashree Sahoo, Israr Ansari, Ajay Kumar, Vivek Dhir, Santosh Karajgi, Abhijeet Dutta, Amin Gasmi, parue dans South African Journal of Botany (2026). DOI:…
Artificial Intelligence-Driven Gene Delivery Systems in Dementia: A Comprehensive Review of Mechanisms, Tools, and Therapeutic Strategies
INTRODUCTION/OBJECTIVE: The progressive nature of dementia is represented by a reduction in two or more cognitive functions, including language, memory, executive and visuospatial functioning, personality, and behavior. Only symptoms can…
Harnessing the Power of Large Language Models for Drug Discovery: A Systematic Review of Current Applications and Future Directions
INTRODUCTION: The demand for inventive approaches to drug discovery has increased due to the rising costs, time, and failure rates in pharmaceutical research. Large Language Models (LLMs), with their sophisticated natural language process…
Gut microbiota as a modulator of HDAC: insights into Alzheimer’s disease treatment
The human gut microbiota (GMB) has a significant impact on physiological function, including gastrointestinal health, immune regulation, and redox homeostasis. It consists of diverse microorganisms that support digestion, nutrient absorpt…
Artificial Intelligence-Driven Diagnosis, Prediction, and Management of Polycystic Ovarian Disease (PCOD): A Comprehensive Systematic Review of Machine Learning, Deep Learning, and Emerging Technologies
INTRODUCTION: Polycystic Ovarian Disease (PCOD) is a complicated endocrine-metabolic disorder affecting about one-quarter of women of reproductive age in the world and a major cause of infertility. This disorder is characterised by hypera…
Nanocarrier-based Drug Delivery Targeting GPCRs: Challenges, Clinical Translation, and Future Prospects for Precision Medicine
Introduction: G-protein Coupled Receptors (GPCRs) are the largest family of classical membrane receptors and the most important class of pharmacological targets, playing roles in many physiological and pathological processes. Targeting a…
A Survey Review of Computational Models and Their Applications in Predicting Drug-Drug Interactions
Introduction: Drug-drug interactions (DDIs) represent a substantial challenge in contemporary pharmacotherapy, especially given polypharmacy, the effects of foods, and the modification of host-microbiota systems on drugs. Although useful,…
The EPR effect in human tumors: a critical re-evaluation of a nanomedicine dogma and a call for new targeting paradigms
For almost four decades, the enhanced permeability and retention (EPR) effect has served as the foundation for passive targeting in cancer nanomedicine. While preclinical studies have reported promising nanoparticle accumulation and thera…
Neuroprotection Through Nature: The Role of Bioactive Phytocompounds in Alzheimer’s and Parkinson’s Disease
INTRODUCTION: Neurodegenerative diseases, notably Alzheimer's Disease (AD) and Parkinson's Disease (PD), represent a significant and growing global health burden, characterized by progressive cognitive and motor dysfunction. Despite advan…
Targeting α-Synuclein Aggregation in Parkinson’s Disease: A Narrative Review of Current Gene Therapy Strategies
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by the accumulation of misfolded α-synuclein (α-syn) aggregates, leading to dopaminergic neuronal loss and motor dysfunction. Current pharmacological treat…
Innovative Drug Delivery Strategies for Enhanced Treatment of Antimicrobial Resistance
INTRODUCTION: Antimicrobial resistance (AMR) presents a major global health threat, driven by the overuse and misuse of antibiotics. Traditional drug delivery systems face significant limitations in effectively addressing this issue, incl…
Parcours
Né en 1985, Amin Gasmi débute dans les sciences du sport et la physiologie à Alger, auprès d’équipes nationales et de clubs. Il poursuit à l’Université Claude Bernard Lyon 1 des masters de recherche en sciences biologiques et de la santé, puis un doctorat en biologie et physiologie.
Sociétés savantes et enseignement
- Fondateur et président de l’IINMS, institut de formation en nutrition et micronutrition pour les professionnels de santé
- Président-fondateur de la Société Francophone de Nutrithérapie et de Nutrigénétique Appliquée (SOFNNA, 2018)
- Président du comité scientifique du congrès ICCHM (Contaminants et Métaux Lourds)
- Membre de l’International Society for Orthomolecular Medicine (ISOM) et de l’IAOMT
Consultation
Les consultations se réservent sur l’espace dédié OrthoDiet : bilans, suivis et rendez-vous en visioconférence.
